دورية أكاديمية

Cost-effectiveness of the addition of CDK4/6 inhibitors to standard endocrine therapy in first-line treatment of women with advanced HR+/HER2− breast cancer in Mexico

التفاصيل البيبلوغرافية
العنوان: Cost-effectiveness of the addition of CDK4/6 inhibitors to standard endocrine therapy in first-line treatment of women with advanced HR+/HER2− breast cancer in Mexico
المؤلفون: Molina-Jaimes, Mariana, Galindo-González, Antonio, Verduzco-Aguirre, Haydeé Cristina, Bautista-Arredondo, Sergio, Reyes-Terán, Gustavo, Soto-Perez-de-Celis, EnriqueAff4, IDs1209402303247w_cor6
المصدر: Clinical and Translational Oncology. 26(1):239-244
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:16993055
DOI:10.1007/s12094-023-03247-w